Jnl Wrist Surg 2019; 08(01): 037-042
DOI: 10.1055/s-0038-1668154
Scientific Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Reduction and Association of the Scaphoid and Lunate: A Functional and Radiographical Outcome Study

William R. Aibinder
1  Mayo Clinic, Rochester, Minnesota
,
Ali Izadpanah
2  University Hospital of Montreal, Montreal, Quebec, Canada
,
Bassem T. Elhassan
1  Mayo Clinic, Rochester, Minnesota
› Author Affiliations
Further Information

Publication History

07 February 2018

04 July 2018

Publication Date:
07 August 2018 (online)

Abstract

Background Management of scapholunate (SL) ligament disruption is a challenging problem. The reduction and association of the scaphoid and lunate (RASL) procedure has been described with varying results. This study assessed the outcomes of the RASL procedure.

Purpose The objective of this study was to assess the outcomes of patients undergoing the RASL procedure at our institution in regard to pain relief, range of motion, radiographic and functional outcomes, complications, and reoperations.

Materials and Methods Twelve patients with symptomatic chronic SL instability underwent the RASL procedure. The mean age was 35 years. The mean time from injury to surgery was 40 weeks. The mean follow-up was 89 months. Outcomes included visual analog score for pain, wrist range of motion, grip strength, and Mayo Wrist Scores. Preoperative and postoperative radiographs were reviewed.

Results Pain scores improved in 10 wrists. Range of motion and grip strength worsened. The average Mayo Wrist Score was 63.3. The mean SL diastasis and angle improved, but seven wrists developed progressive degenerative changes, with two requiring a salvage procedure. Symptomatic progressive screw lucency occurred in eight wrists requiring screw removal.

Conclusion The RASL procedure can improve SL widening but has a high rate of early failure and reoperation. Following reoperation, long-term follow-up demonstrates reasonable long-term durability in some cases.

Level of Evidence This is a Level IV, therapeutic case study.

Note

This work was performed at the Mayo Clinic, Rochester, MN.


Ethical Approval

This study underwent Institutional Review Board (IRB) approval by an internal ethical committee approving the study (IRB number: 15–002433).